Anika Therapeutics Inc (ANIK.OQ)

ANIK.OQ on NASDAQ Stock Exchange Global Select Market

24.32USD
4:00pm EDT
Price Change (% chg)

$4.21 (+20.93%)
Prev Close
$20.11
Open
$23.52
Day's High
$25.88
Day's Low
$23.52
Volume
130,510
Avg. Vol
28,510
52-wk High
$25.88
52-wk Low
$9.13

ANIK.OQ

Chart for ANIK.OQ

About

Anika Therapeutics, Inc. (Anika) develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. As of December 31, 2011, Anika’s wholly owned subsidiary, Anika... (more)

Overall

Beta: 1.53
Market Cap (Mil.): $281.46
Shares Outstanding (Mil.): 14.00
Dividend: --
Yield (%): --

Financials

  ANIK.OQ Industry Sector
P/E (TTM): 19.26 47.13 37.76
EPS (TTM): 1.04 -- --
ROI: 11.69 -2.58 18.76
ROE: 13.69 -2.66 19.59
Search Stocks

Competitors

  Price Change
Pfizer Inc. (PFE.N) $29.11 -0.12
Johnson & Johnson (JNJ.N) $93.77 +0.27
Novartis AG (NOVN.VX) CHF66.60 +0.35
Merck & Co., Inc. (MRK.N) $48.58 +0.41
Roche Holding Ltd. (ROG.VX) CHF228.00 -3.50
Abbott Laboratories (ABT.N) $36.84 +0.21
Bayer AG (BAYGn.DE) €89.43 +2.08
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €76.85 -3.32
Bristol Myers Squibb Co. (BMY.N) $43.99 +0.75

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks